GE HealthCare showcases latest AI-enhanced cardiology solutions to enable real-time cardiac imaging and assessments at the point of care at ESC 2024

GE HealthCare showcases latest AI-enhanced cardiology solutions to enable real-time cardiac imaging and assessments at the point of care at ESC 2024

GE HealthCare has announced the CE marks of its Vscan Air SL wireless handheld ultrasound system with Caption AI (Vscan Air SL with Caption AI), an Artificial Intelligence (AI)-driven software for rapid cardiac assessments at the point of care, as well as ECG-less Cardiac computed tomography (CT) scanning on its Revolution Apex platform, which allows clinicians to acquire cardiac images without the aid of the patients’ electrocardiogram (ECG) signal/trace. Both technologies were showcased at the European Society of Cardiology (ESC) Congress, in London last month. 

“With diseases of the heart and blood vessels representing nearly one-third of all global deaths, innovation within cardiac diagnostics and treatment is one of our top priorities as a healthcare company,” said Phil Rackliffe, President and CEO of Ultrasound and Image Guided Therapies, GE HealthCare. “The integration of Caption AI on Vscan Air SL is a major step toward helping more users confidently capture diagnostic-quality images to inform clinical decisions when time is of the essence. With the recent CE mark, we’re eager to bring this technology to more healthcare providers around the world.”